• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈萨克斯坦宫颈癌发病率的新趋势。

New Trends of Cervical Cancer Incidence in Kazakhstan.

机构信息

Astana Medical University, Nur-Sultan, Kazakhstan.

Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.

出版信息

Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1295-1304. doi: 10.31557/APJCP.2021.22.4.1295.

DOI:10.31557/APJCP.2021.22.4.1295
PMID:33906325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8325133/
Abstract

OBJECTIVE

The epidemiological features of the cervical cancer (CC) incidence and its spatial and temporal assessment in Kazakhstan were studied.

METHODS

The retrospective study was done for the period 2009-2018. Descriptive and analytical methods of oncoepidemiology were used.

RESULTS

During the study period, 16,441 new cases of CC were registered. The average annual crude and age-standardized incidence rate were 18.6±0.5 and 17.7±0.4 cases per 100,000 population of female, respectively, and their trends tended to increase (Тup=+2.3%; R2=0.708 and Тup=+1.9%; R2=0.615, respectively). The analysis of ASIR showed unimodal growth with a peak at 50-54 years - 45.3±1.1 cases per 100,000 population of female. Trends of ASIR decreased up to 30 years (Tdown=-1.8%; R2=0.111) and 35-59 years (Tdown=-0.9%; R2=0.103), in other age groups the trends increased, and were most pronounced in 40-44 (Тup=+4.1%; R2=0.878) and 65-69 years (Тup=+4.4%; R2=0.537). Trends in ASR of СС tended to grow in almost all regions, with higher levels in Mangystau (Тup=+4.1%; R2=0.482) and Aktobe (Тup=+6.3%; R2=0.846) regions. The cartograms of ASR per 100,000 population of female were allocated according to the following criteria: low - up to 16.3, average - from 16.3 to 19.2, high - above 19.2. The results of the spatial analysis showed the regions with a higher levels of CC incidence rate per 100,000 population of female: East Kazakhstan (19.8), Aktobe (20.0), Almaty (20.1), Kostanay region (20.9), Atyrau (21.7) regions and Almaty city (22.0).

CONCLUSION

The study of trends of the cervical cancer incidence has the theoretical and practical value:  monitoring and evaluation of screening programmes, which are implemented in the country, and conduction of secondary prevention of cervical pathology. Health authorities should consider the obtained results in the in the organization of anti-cancer activities.

摘要

目的

研究哈萨克斯坦宫颈癌(CC)发病率的流行病学特征及其时空评估。

方法

本研究为回顾性研究,时间范围为 2009 年至 2018 年。采用描述性和分析性肿瘤流行病学方法。

结果

研究期间,共登记了 16441 例新的宫颈癌病例。平均年粗发病率和年龄标准化发病率分别为每 10 万女性 18.6±0.5 和 17.7±0.4 例,呈上升趋势(Tup=+2.3%;R2=0.708 和 Tup=+1.9%;R2=0.615)。年龄标准化发病率分析显示出单峰增长,峰值出现在 50-54 岁,为每 10 万女性 45.3±1.1 例。30 岁以下(Tdown=-1.8%;R2=0.111)和 35-59 岁(Tdown=-0.9%;R2=0.103)的年龄标准化发病率趋势下降,其他年龄组的趋势上升,40-44 岁(Tup=+4.1%;R2=0.878)和 65-69 岁(Tup=+4.4%;R2=0.537)的上升最为显著。宫颈癌的年龄标准化发病率趋势在几乎所有地区都呈上升趋势,曼格斯套州(Tup=+4.1%;R2=0.482)和阿克托贝州(Tup=+6.3%;R2=0.846)的水平较高。根据以下标准对每 10 万女性的年龄标准化发病率进行了制图:低-至 16.3,平均-16.3 至 19.2,高-超过 19.2。空间分析的结果显示了每 10 万女性宫颈癌发病率较高的地区:东哈萨克斯坦州(19.8)、阿克托贝州(20.0)、阿拉木图州(20.1)、科斯塔奈州(20.9)、阿特劳州(21.7)和阿拉木图市(22.0)。

结论

对宫颈癌发病率趋势的研究具有理论和实践价值:监测和评估在该国实施的筛查计划,并开展宫颈癌二级预防。卫生当局应在组织抗癌活动时考虑到所获得的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/8325133/d0ee448add17/APJCP-22-1295-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/8325133/abc848425e4a/APJCP-22-1295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/8325133/cac1834c880f/APJCP-22-1295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/8325133/d0ee448add17/APJCP-22-1295-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/8325133/abc848425e4a/APJCP-22-1295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/8325133/cac1834c880f/APJCP-22-1295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/8325133/d0ee448add17/APJCP-22-1295-g003.jpg

相似文献

1
New Trends of Cervical Cancer Incidence in Kazakhstan.哈萨克斯坦宫颈癌发病率的新趋势。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1295-1304. doi: 10.31557/APJCP.2021.22.4.1295.
2
Breast Cancer Incidence in Kyrgyzstan: Report of 15 Years of Cancer Registry.吉尔吉斯斯坦乳腺癌发病率:15 年癌症登记报告。
Asian Pac J Cancer Prev. 2022 May 1;23(5):1603-1610. doi: 10.31557/APJCP.2022.23.5.1603.
3
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.哈萨克斯坦子宫体癌:近期发病趋势。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):849-857. doi: 10.31557/APJCP.2023.24.3.849.
4
Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.哈萨克斯坦肺癌的流行病学:趋势和地理分布。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1521-1532. doi: 10.31557/APJCP.2023.24.5.1521.
5
Colorectal Cancer Mortality in Kazakhstan: Spatio-Temporal Epidemiological Assessment.哈萨克斯坦结直肠癌死亡率:时空流行病学评估。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):953-960. doi: 10.31557/APJCP.2022.23.3.953.
6
Epidemiology of Breast Cancer Mortality in Kazakhstan, trends and Geographic Distribution.哈萨克斯坦乳腺癌死亡率的流行病学,趋势和地理分布。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3361-3371. doi: 10.31557/APJCP.2023.24.10.3361.
7
Lymphosarcoma Incidence in Kazakhstan: A Retrospective Survey (2010-2019).哈萨克斯坦淋巴肉瘤发病率:回顾性调查(2010-2019 年)。
Asian Pac J Cancer Prev. 2023 Jun 1;24(6):1885-1896. doi: 10.31557/APJCP.2023.24.6.1885.
8
Trend in Gastric Cancer Mortality in Kazakhstan.哈萨克斯坦胃癌死亡率趋势。
Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3779-3789. doi: 10.31557/APJCP.2022.23.11.3779.
9
Hypopharynx Cancer Incidence in Kazakhstan: 2017-2021.哈萨克斯坦下咽癌发病率:2017-2021 年。
Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4043-4051. doi: 10.31557/APJCP.2023.24.12.4043.
10
Liver Cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study.哈萨克斯坦的肝癌发病率:十五年回顾性研究。
Asian Pac J Cancer Prev. 2024 May 1;25(5):1763-1775. doi: 10.31557/APJCP.2024.25.5.1763.

引用本文的文献

1
Cervical cancer trend in the Republic of Kazakhstan and attitudes towards cervical cancer screening in urban and rural areas.哈萨克斯坦共和国的宫颈癌趋势及城乡地区对宫颈癌筛查的态度。
Sci Rep. 2024 Jun 14;14(1):13731. doi: 10.1038/s41598-024-64566-8.
2
Allicin inhibits the biological activities of cervical cancer cells by suppressing circEIF4G2.大蒜素通过抑制circEIF4G2来抑制宫颈癌细胞的生物学活性。
Food Sci Nutr. 2024 Jan 4;12(4):2523-2536. doi: 10.1002/fsn3.3935. eCollection 2024 Apr.
3
Vaccination Effectiveness against Human Papillomavirus in Kazakhstan.

本文引用的文献

1
Cervical cancer: Epidemiology, risk factors and screening.宫颈癌:流行病学、危险因素与筛查
Chin J Cancer Res. 2020 Dec 31;32(6):720-728. doi: 10.21147/j.issn.1000-9604.2020.06.05.
2
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.普通风险人群的宫颈癌筛查:美国癌症协会 2020 年指南更新。
CA Cancer J Clin. 2020 Sep;70(5):321-346. doi: 10.3322/caac.21628. Epub 2020 Jul 30.
3
Cervical Dysplasia, Infection, and Phylogeny of Human Papillomavirus in HIV-Infected and HIV-Uninfected Women at a Reproductive Health Clinic in Nairobi, Kenya.
哈萨克斯坦的 HPV 疫苗效力。
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):681-688. doi: 10.31557/APJCP.2024.25.2.681.
4
Prevalence of high-risk human papillomavirus infection and genotype distribution among Kazakhstani women with abnormal cervical cytology.哈萨克斯坦女性宫颈细胞学异常者高危型人乳头瘤病毒感染及基因型分布。
Ann Med. 2024 Dec;56(1):2304649. doi: 10.1080/07853890.2024.2304649. Epub 2024 Jan 18.
5
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.哈萨克斯坦子宫体癌:近期发病趋势。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):849-857. doi: 10.31557/APJCP.2023.24.3.849.
6
Prevalence of Precancerous Cervical Lesions among Nonvaccinated Kazakhstani Women: The National Tertiary Care Hospital Screening Data (2018).未接种疫苗的哈萨克斯坦女性宫颈癌前病变患病率:国家三级医疗医院筛查数据(2018年)
Healthcare (Basel). 2023 Jan 12;11(2):235. doi: 10.3390/healthcare11020235.
7
What Factors Are Associated with Attitudes towards HPV Vaccination among Kazakhstani Women? Exploratory Analysis of Cross-Sectional Survey Data.哈萨克斯坦女性对人乳头瘤病毒(HPV)疫苗接种的态度与哪些因素相关?横断面调查数据的探索性分析
Vaccines (Basel). 2022 May 23;10(5):824. doi: 10.3390/vaccines10050824.
8
The Distribution and Prevalence of High-Risk HPV Genotypes Other than HPV-16 and HPV-18 among Women Attending Gynecologists' Offices in Kazakhstan.哈萨克斯坦妇科门诊女性中除HPV-16和HPV-18外的高危型HPV基因型的分布与流行情况
Biology (Basel). 2021 Aug 18;10(8):794. doi: 10.3390/biology10080794.
肯尼亚内罗毕一家生殖健康诊所中 HIV 感染者和未感染者的宫颈发育不良、感染以及人乳头瘤病毒的系统发育
Biomed Res Int. 2020 Jun 16;2020:4945608. doi: 10.1155/2020/4945608. eCollection 2020.
4
Epigenetic Regulation of the Human Papillomavirus Life Cycle.人乳头瘤病毒生命周期的表观遗传调控
Pathogens. 2020 Jun 18;9(6):483. doi: 10.3390/pathogens9060483.
5
Cancer prevention: cervical cancer.癌症预防:宫颈癌
Ecancermedicalscience. 2019 Jul 25;13:952. doi: 10.3332/ecancer.2019.952. eCollection 2019.
6
HPV Types Distribution in General Female Population and in Women Diagnosed with Cervical Cancer Across Western Kazakhstan.哈萨克斯坦西部普通女性人群及被诊断为宫颈癌的女性中HPV类型分布情况
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1089-1096. doi: 10.31557/APJCP.2019.20.4.1089.
7
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Epidemiology of HPV Infection and HPV-Related Cancers in Kazakhstan: a Review.哈萨克斯坦人乳头瘤病毒感染及人乳头瘤病毒相关癌症的流行病学:综述
Asian Pac J Cancer Prev. 2018 May 26;19(5):1175-1180. doi: 10.22034/APJCP.2018.19.5.1175.
10
Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline.浸润性宫颈癌女性的管理与护理:美国临床肿瘤学会资源分层临床实践指南
J Glob Oncol. 2016 May 25;2(5):311-340. doi: 10.1200/JGO.2016.003954. eCollection 2016 Oct.